AU5372998A - Antisense oligonucleotides specific for cdk4 - Google Patents

Antisense oligonucleotides specific for cdk4

Info

Publication number
AU5372998A
AU5372998A AU53729/98A AU5372998A AU5372998A AU 5372998 A AU5372998 A AU 5372998A AU 53729/98 A AU53729/98 A AU 53729/98A AU 5372998 A AU5372998 A AU 5372998A AU 5372998 A AU5372998 A AU 5372998A
Authority
AU
Australia
Prior art keywords
cdk4
antisense oligonucleotides
oligonucleotides specific
specific
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53729/98A
Inventor
David Morrissey
Eric Von Hofe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aceragen Inc
Original Assignee
Hybridon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybridon Inc filed Critical Hybridon Inc
Publication of AU5372998A publication Critical patent/AU5372998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU53729/98A 1997-11-21 1997-11-21 Antisense oligonucleotides specific for cdk4 Abandoned AU5372998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/022234 WO1999027087A1 (en) 1997-11-21 1997-11-21 Antisense oligonucleotides specific for cdk4

Publications (1)

Publication Number Publication Date
AU5372998A true AU5372998A (en) 1999-06-15

Family

ID=22262206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53729/98A Abandoned AU5372998A (en) 1997-11-21 1997-11-21 Antisense oligonucleotides specific for cdk4

Country Status (2)

Country Link
AU (1) AU5372998A (en)
WO (1) WO1999027087A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054974A1 (en) * 2000-11-06 2002-06-06 Epigenomics Ag Diagnosis of diseases associated with Cdk4
GB2387385A (en) * 2002-03-25 2003-10-15 Theryte Ltd Chemotherapeutic agents for treating cancer
ES2320437T3 (en) * 2002-03-25 2009-05-22 Theryte Limited CANCER TREATMENT.
US20040180844A1 (en) * 2003-03-10 2004-09-16 Fesik Stephen W. Method of killing cancer cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell

Also Published As

Publication number Publication date
WO1999027087A1 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
AU9023798A (en) Mdm2-specific antisense oligonucleotides
AU8938098A (en) Liposomes containing oligonucleotides
AU5441896A (en) Cooperative oligonucleotides
AU3811897A (en) Antisense oligonucleotides as antibacterial agents
AU5259498A (en) Antisense oligonucleotides
AU1124699A (en) Liposomal oligonucleotide compositions for modulating ras gene expression
AU3340797A (en) Modified oligonucleotides
AU7918398A (en) Oligonucleotide derivatives
AU1279397A (en) Modified vegf antisense oligonucleotides
AU6842898A (en) Integrated dispense system
AU6186398A (en) Process for selecting anti-sense oligonucleotides
AU1156699A (en) Antisense oligonucleotides against tenascin for treating vitiligo
AU6253399A (en) Dual use dispensing system
AU6536698A (en) Anti-sense oligonucleotide pharmacological agents
AU4173497A (en) Monocot seed gene expression system
AU6328498A (en) Oligonucleotides specific for the (marorab) operon
AUPO759797A0 (en) Dispenser
AU5372998A (en) Antisense oligonucleotides specific for cdk4
AU7364998A (en) Antisense oligonucleotides specific for thymidylate synthase
AU7261398A (en) Processes for preparing benzothiophenes
AU8333698A (en) Dispenser
AU2551499A (en) Suspension system for dispensers
AU8333598A (en) Dispensing system
AU5314999A (en) Modified oligonucleotides
AUPP438598A0 (en) NPY-Y7 receptor gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase